PBM reform represents a tremendous opportunity. It might be one of the only significant, consequential areas of true ...

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...

On December 11, 2024, a bill was introduced in the U.S. House of Representatives that, if enacted, would have substantial implications for ...

The parents of Cole Schmidtknecht, 22, are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the Wisconsin man's death in 2024.

Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

Better decision-making and more efficient claim handling are two outcomes of the revolution taking place in workers’ ...

As prescription drug prices continue to spiral and federal efforts to control them stall, state lawmakers are focusing on ...

A bill that would subject pharmacy benefit managers to licensing by the state Department of Insurance faces a hurdle: Gov.

CVS Health is seeing signs of stabilization in key business areas, prompting Leerink Partners to upgrade the stock from Market Perform to Outperform and raise its price target to $75 per share in a ...

The Pharmaceutical Care Management Association PCMA) – which represents the PBM sector – said in a statement that the new report "again fails to consider the entirety of the prescription drug ...